<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05030766</url>
  </required_header>
  <id_info>
    <org_study_id>20201296</org_study_id>
    <nct_id>NCT05030766</nct_id>
  </id_info>
  <brief_title>Testing Integrative Smoking Cessation for Hispanic HIV Patients</brief_title>
  <official_title>A Pilot SMART Pre- and Post-testing of an Integrative Mindfulness-Based Smoking Cessation Intervention for Hispanic HIV Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the feasibility, acceptability and effect of a&#xD;
      combined smoking cessation intervention integrating contingency management (reward-based)&#xD;
      strategies with Mindfulness training to identify the optimal dynamic strategy to promote&#xD;
      smoking cessation among Hispanic HIV patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">January 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2023</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants reporting 7-day point-prevalence abstinence</measure>
    <time_frame>Up to 22 weeks</time_frame>
    <description>Defined as self-report of not smoking in the past 7-days, not even a puff and confirmed by expired carbon monoxide (CO) level of &lt; 6 ppm.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of enrolled participants</measure>
    <time_frame>Baseline</time_frame>
    <description>Study feasibility will be reported as the number of participants that were screened and enrolled per month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average enrollment time</measure>
    <time_frame>Baseline</time_frame>
    <description>Study feasibility will be reported as the average time to enroll participants to form classes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retention rate</measure>
    <time_frame>Up to 22 weeks</time_frame>
    <description>Treatment specific retention rates will be reported as the number of participants completing all study procedures dived by the total of participants enrolled.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of completed study measures</measure>
    <time_frame>Up to 22 weeks</time_frame>
    <description>Defined as number of in-person session attended, and number of homework assignments completed.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Smoking</condition>
  <condition>Smoking Cessation</condition>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>MT plus NRT Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants who receive the Mindfulness Training (MT) intervention for 4 weeks in addition to 6 weeks of Nicotine Replacement Therapy (NRT).These participants are responders (have quit smoking at the 1 month follow up) or non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive no additional intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CM plus NRT Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants who receive the Contingency Management (CM) intervention for 4 weeks in addition to 6 weeks of NRT. These participants are responders (have quit smoking at the 1 month follow up) or non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive no additional intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MT plus NRT with additional CM Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants who received the MT intervention for 4 weeks with 6 weeks of NRT and are non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive an additional CM intervention for another 4 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CM plus NRT with additional MT Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants who received the CM intervention for 4 weeks with 6 weeks of NRT and are non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive an additional MT intervention for another 4 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine Replacement Therapy</intervention_name>
    <description>6 weeks of Nicotine replacement patches</description>
    <arm_group_label>CM plus NRT Group</arm_group_label>
    <arm_group_label>CM plus NRT with additional MT Group</arm_group_label>
    <arm_group_label>MT plus NRT Group</arm_group_label>
    <arm_group_label>MT plus NRT with additional CM Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness Training Smoking Cessation Intervention</intervention_name>
    <description>Mindfulness Training Smoking Cessation Intervention administered online via Zoom. Each session lasts 60-90 minutes, twice weekly for 4 weeks for a total of 8 sessions.</description>
    <arm_group_label>CM plus NRT with additional MT Group</arm_group_label>
    <arm_group_label>MT plus NRT Group</arm_group_label>
    <arm_group_label>MT plus NRT with additional CM Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Contingency Management Smoking Cessation Intervention</intervention_name>
    <description>Contingency Management Smoking Cessation Intervention includes one orientation session lasting about 60-90 minutes administered via Zoom. Participants will then be required to contact the research associate about their quitting progress three times a week for 4 weeks also by zoom.</description>
    <arm_group_label>CM plus NRT Group</arm_group_label>
    <arm_group_label>CM plus NRT with additional MT Group</arm_group_label>
    <arm_group_label>MT plus NRT with additional CM Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosed with HIV (based on self-report).&#xD;
&#xD;
          -  Be 18 years and older&#xD;
&#xD;
          -  Have smoked â‰¥ 5 cigarettes/day in the past year&#xD;
&#xD;
          -  Be interested in making a quit attempt in the next 30 days&#xD;
&#xD;
          -  Self-identified as Hispanic ethnicity&#xD;
&#xD;
          -  Able to consent&#xD;
&#xD;
          -  Have no plans to move in the next 3 months&#xD;
&#xD;
          -  Are not pregnant or planning to be pregnant in the following 3 months&#xD;
&#xD;
          -  Have any condition that, in the opinion of the investigator, would compromise the&#xD;
             well-being of the patient or the study or prevent the patient from meeting or&#xD;
             performing study requirements&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Have contraindication to NRT (past month myocardial infarction, history of serious&#xD;
             arrhythmias/or unstable angina pectoris, dermatological disorder)&#xD;
&#xD;
          -  Are currently being treated for a psychiatric condition.&#xD;
&#xD;
          -  Are currently being treated for smoking cessation, alcoholism, or illicit drug use&#xD;
&#xD;
          -  Are adults unable to consent&#xD;
&#xD;
          -  Are individuals who are not yet adults&#xD;
&#xD;
          -  Are pregnant women&#xD;
&#xD;
          -  Are prisoners&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Taghrid A. Asfar, MD, MSPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Taghrid Asfar, MD, MSPH</last_name>
    <phone>3052433826</phone>
    <email>tasfar@med.miami.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laura McClure, MSPH</last_name>
    <phone>5185848391</phone>
    <email>lmcclure@med.miami.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Taghrid Asfar, MD, MSPH</last_name>
      <phone>305-243-3826</phone>
      <email>tasfar@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Taghrid Asfar, MD, MSPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 26, 2021</study_first_submitted>
  <study_first_submitted_qc>August 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2021</study_first_posted>
  <last_update_submitted>October 8, 2021</last_update_submitted>
  <last_update_submitted_qc>October 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Taghrid Asfar</investigator_full_name>
    <investigator_title>Research Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Mindfulness Training</keyword>
  <keyword>Contingency Management</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

